Mia's Feed
Medical News & Research

Why Many Women Are Choosing Crisis Pregnancy Centers Despite Misinformation Concerns

Why Many Women Are Choosing Crisis Pregnancy Centers Despite Misinformation Concerns

Share this article

A new study reveals that up to 20% of women in certain U.S. states attend crisis pregnancy centers, despite concerns over misinformation and lack of medical licensing. Learn about the impact on reproductive health.

2 min read

Recent research highlights that a significant number of women in the United States have visited crisis pregnancy centers (CPCs) for pregnancy-related support, even amid ongoing concerns about misinformation and their lack of proper medical licensing. A study analyzing data from 2018 to 2020 across four states—Arizona, Wisconsin, Iowa, and New Jersey—found that between 12% and 20% of women who experienced pregnancy or testing for pregnancy reported visiting CPCs. The highest attendance was observed in Arizona at 20.2%, while New Jersey had the lowest at 11.6%. The other states, Wisconsin and Iowa, showed similar rates of approximately 14%. Notably, the study revealed no significant link between CPC visitation and factors such as age, race, or socioeconomic status.

Crisis pregnancy centers are often mistaken for medical facilities or abortion clinics, yet they are typically unlicensed and may provide inaccurate information about sexual and reproductive health. These centers focus on promoting anti-abortion missions, opposing contraception, and advocating for abstinence outside of marriage. They are increasingly funded by public dollars, despite not adhering to established medical safety standards. This raises concerns about the quality of care and the potential impact of misinformation on women's health.

The findings emphasize the importance of healthcare providers being aware that their pregnant patients may have previously attended CPCs and been exposed to misleading information. As the landscape of reproductive healthcare continues to evolve, especially following recent legal changes, understanding the prevalence of CPC attendance can inform better patient education and care strategies. This pre-Dobbs data serves as a crucial benchmark for assessing how CPC involvement influences pregnancy-related health outcomes in the future.

In conclusion, the study underscores the need for reliable healthcare sources and warns against relying on unlicensed centers for medical advice, given their role in spreading misinformation. Women seeking pregnancy care should be encouraged to consult licensed healthcare professionals to ensure accurate information and safe, evidence-based treatment.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Pre-Surgical Combination Therapy Enhances Survival in Rare Thyroid Cancer Patients

Combining pembrolizumab with targeted therapies significantly improves survival and surgical resection rates in patients with aggressive BRAF-mutated anaplastic thyroid cancer.

Emerging Challenges of GLP-1 Agonists in PET-CT Imaging

New research at EANM 2025 highlights how GLP-1 receptor agonists can alter PET-CT scans, potentially leading to misdiagnosis in cancer imaging. Awareness and careful medication documentation are key to accurate interpretation.

Early Detection of Alzheimer's Disease Through Routine Eye Examinations

Emerging research indicates that routine eye exams could help detect early signs of Alzheimer's disease by revealing vascular changes in the retina, offering a promising avenue for early diagnosis and intervention.

Elevated Alzheimer's Biomarker Detected in Newborns: A Closer Look at Phosphorylated Tau

New research reveals that newborns naturally have high levels of a key Alzheimer's biomarker, p-tau217, which may play a crucial role in brain development and offer insights for future Alzheimer's treatments.